Biggest News Aggregation in the World

Hill Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hill Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hill Bio Today - Breaking & Trending Today

Oak Hill Bio and Chiesi Group Announce First Patient Enrolled in the Resumed Phase 2b Clinical Study Evaluating OHB-607 for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease in Premature Infants

Published: May 18, 2024

Design of the multi-center study is based on Phase 2a clinical data, which showed a decrease in the occurrence of severe bronchopulmonary dysplasia (BPD), a condition for which there are

Source: tigersroar.com

Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula: A Randomized Clinical Trial | Critical Care Medicine | JAMA

Published: February 17, 2024

This randomized clinical trial compares the effect of donor human milk on neurodevelopmental outcomes at 22 to 26 months’ corrected age compared with preterm in

Source: jamanetwork.com

Chiesi Group and Oak Hill Bio announce License and Development Agreement to develop, manufacture, and commercialise OHB-

Published: January 9, 2024

PARMA, Italy and CAMBRIDGE, Mass., Jan. 9, 2024 /PRNewswire/ -- Chiesi Farmaceutici S.p.A ("Chiesi Group"),...

Source: europapress.es

Bronchopulmonary Dysplasia Market to Register Growth at an Extraordinary CAGR of 66.2% by 2032

Published: September 14, 2022

/PRNewswire/ -- DelveInsight's Bronchopulmonary Dysplasia Market Insights report includes a comprehensive understanding of current treatment practices,...

Source: prnewswire.com

Oak Hill Bio to Participate in Citi 17th Annual BioPharma Conference

Published: September 2, 2022

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com